Evidence map›Paper›PMID 29910000›Full record

ArticleNeuron2018

Biallelic Mutations in MYORG Cause Autosomal Recessive Primary Familial Brain Calcification.

Xiang-Ping Yao, Xuewen Cheng, Chong Wang, Miao Zhao, Xin-Xin Guo, Hui-Zhen Su, Lu-Lu Lai, Xiao-Huan Zou, Xue-Jiao Chen, Yuying Zhao and 10 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Neuron, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. RRP12 Variants Are Associated With Autosomal Recessive Brain Calcifications.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  6. Update on Genetic Chorea.European journal of neurology · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Rare Presentation of Homozygous SCase reports in genetics · 2025
    Article
  14. Article
  15. Article
  16. NovelJournal of clinical neurology (Seoul, Korea) · 2024
    Article
  17. Article
  18. Article
  19. JAM2 variants can be more common in primary familial brain calcification (PFBC) cases than those appear; may be due to a founder mutation.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Xiang-Ping YaoDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Xuewen ChengInstitute of Neuroscience and State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Chong WangDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Miao ZhaoDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Xin-Xin GuoDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Hui-Zhen SuDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Lu-Lu LaiDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Xiao-Huan ZouDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Xue-Jiao ChenDepartment of Neurology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou 363000, China.
Yuying ZhaoLaboratory of Neuromuscular Disorders and Department of Neurology, Qilu Hospital, Shandong University, Jinan 250012, China.
En-Lin DongDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Ying-Qian LuDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Shuang WuDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China.
Xiaojuan LiSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Gaofeng FanSchool of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Hongjie YuProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL 60201, USA.
Jianfeng XuProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL 60201, USA.
Ning WangDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China; Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou 350005, China. Electronic address: ningwang@fjmu.edu.cn.
Zhi-Qi XiongInstitute of Neuroscience and State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China. Electronic address: xiongzhiqi@ion.ac.cn.
Wan-Jin ChenDepartment of Neurology and Institute of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China; Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou 350005, China. Electronic address: wanjinchen75@fjmu.edu.cn.
Fujian Medical University · CNChinese Academy of Sciences · CNNorthShore University HealthSystem · USShanghaiTech University · CNQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary familial brain calcification (PFBC) is a genetically heterogeneous disorder characterized by bilateral calcifications in the basal ganglia and other brain regions. The genetic basis of this disorder remains unknown in a significant portion of familial cases. Here, we reported a recessive causal gene, MYORG, for PFBC. Compound heterozygous or homozygous mutations of MYORG co-segregated completely with PFBC in six families, with logarithm of odds (LOD) score of 4.91 at the zero recombination fraction. In mice, Myorg mRNA was expressed specifically in S100β-positive astrocytes, and knockout of Myorg induced the formation of brain calcification at 9 months of age. Our findings provide strong evidence that loss-of-function mutations of MYORG cause brain calcification in humans and mice.

Indexed as

Loss of Function MutationAdultAgedAllelesAnimalsAstrocytesBrain DiseasesCalcinosisCase-Control StudiesFemaleGlycoside HydrolasesHumansMaleMiceMice, KnockoutMiddle AgedGlycoside HydrolasesMYORG protein, humanMyorg protein, mouseRNA, Messengerastrocytebrain calcificationglycosidaseMYORGPFBC

Identifiers

PMID29910000
OpenAlexW2808209916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.